Stephen Krahling was a published cancer researcher when vaccine maker Merck brought him on board as a virologist in 1999. That’s when he says he found himself embroiled in an all-hands-on-deck ...

Organon pleasantly surprised me with its financial results for Q4 2024. Read why I believe OGN is an attractive stock for ...

We recently published a list of 10 Best Magic Formula Stocks for 2025. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best magic formula stocks ...

Value investing has long been a preferred strategy among investors, largely influenced by Warren Buffett, who continues to ...

Merck & Co. shows strong financial health ... The valuations compare growth rates of EPS, Book Value, and Total Equity. In the table below, you can see the different scenarios, and in the chart ...

As we near the five-year anniversary of the COVID-19 pandemic, it's a good time to revisit the drugmaker stock that was top ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

On March 4, 2025, filings revealed that CEO Stephane Bancel purchased 160,314 shares of MRNA stock between $31.04 and $31.53, ...

We recently published a list of 10 Best Magic Formula Stocks for 2025. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best magic formula stocks ...

Dow jumps 400 points, but US stocks remain on track for steep losses. S&P 500 enters correction, Nasdaq nears bear market.

Workhuman chief executive Eric Mosley on the strategic use of recognition and the untapped value of human data to drive ...